Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study
Uyaroğlu et al., Acta Medica, doi:10.32552/2022.ActaMedica.719
https://c19early.org/uyaroglua.html